Association between azithromycin therapy and duration of bacterial shedding among patients with shiga toxin-producing enteroaggregative Escherichia coli O104:H4

JAMA

Volumn 307, Issue 10, 2012, Pages 1046-1052

  Nitschke, Martin ^a   Sayk, Friedhelm ^a   Härtel, Christoph ^a   Roseland, Rahel Tabea ^a   Hauswaldt, Susanne ^a   Steinhoff, Jürgen ^a   Fellermann, Klaus ^a   Derad, Inge ^a   Wellhöner, Peter ^a   Büning, Jürgen ^a   Tiemer, Bettina ^b   Katalinic, Alexander ^b   Rupp, Jan ^a   Lehnert, Hendrik ^a   Solbach, Werner ^a   Knobloch, Johannes K M ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL SHEDDING; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFICACY; ENTEROAGGREGATIVE ESCHERICHIA COLI; ERADICATION THERAPY; ESCHERICHIA COLI INFECTION; FECES ANALYSIS; FEMALE; FOLLOW UP; HEMOLYTIC UREMIC SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; AGED; DRUG EFFECT; EPIDEMIC; GERMANY; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL SHEDDING; CARRIER STATE; DISEASE OUTBREAKS; ESCHERICHIA COLI INFECTIONS; FEMALE; GERMANY; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SHIGA-TOXIGENIC ESCHERICHIA COLI;

EID: 84858247399     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.264     Document Type: Article

References (26)

1. Frank C, Werber D, Cramer JP, et al HUS Investigation Team. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med. 2011;365(19):1771-1780.
2. Bielaszewska M, Mellmann A, Zhang W, et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: amicrobiological study. Lancet Infect Dis. 2011;11(9):671-676.
3. Rasko DA, Webster DR, Sahl JW, et al. Origins of the E coli strain causing an outbreak of hemolyticuremic syndrome in Germany. N Engl J Med. 2011; 365(8):709-717.
4. Scheutz F, Nielsen EM, Frimodt-Møller J, et al. Characteristics of the enteroaggregative Shiga toxin/ verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill. 2011; 16(24):19889.
5. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342(26):1930-1936. (Pubitemid 30419087)
6. de la Cabada Bauche J, Dupont HL. New developments in traveler's diarrhea. Gastroenterol Hepatol (N Y). 2011;7(2):88-95.
7. Hill DR, Beeching NJ. Travelers' diarrhea. Curr Opin Infect Dis. 2010;23(5):481-487.
8. Mead PS, Griffin PM. Escherichia coli O157:H7. Lancet. 1998;352(9135):1207-1212. (Pubitemid 28458545)
9. Okhuysen PC, Dupont HL. Enteroaggregative Escherichia coli (EAEC): a cause of acute and persistent diarrhea of worldwide importance. J Infect Dis. 2010;202(4):503-505.
10. Okeke IN, Nataro JP. Enteroaggregative Escherichia coli. Lancet Infect Dis. 2001;1(5):304-313. (Pubitemid 33586611)
11. Lapeyraque AL, Malina M, Fremeaux-Bacchi V, et al. Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med. 2011;364(26):2561-2563.
12. Parker C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet. 2009;373(9665):759-767.
13. Robert Koch Institute. Ausbruchs-Falldefinition für EHEC- und HUS-Fälle im Rahmen des Ausbruchs im Frühjahr 2011 in Deutschland [outbreak case definition for EHEC and HUS cases during the spring 2011 outbreak in Germany]. http://www.rki.de/cln-153/nn-467482/DE/Content/InfAZ/E/EHEC/ Falldefinition.html. Accessed July 1, 2011.
14. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365(9464):1073-1086. (Pubitemid 40386785)
15. Safdar N, Said A, Gangnon RE, Maki DG. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA. 2002;288(8):996-1001. (Pubitemid 34920465)
16. Kimmitt PT, Harwood CR, Barer MR. Toxin gene expression by Shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis. 2000;6(5):458-465.
17. McGannon CM, Fuller CA, Weiss AA. Different classes of antibiotics differentially influence Shiga toxin production. Antimicrob Agents Chemother. 2010;54(9):3790-3798.
18. Pedersen MG, Hansen C, Riise E, Persson S, Olsen KE. Subtype-specific suppression of Shiga toxin 2 released from Escherichia coli upon exposure to protein synthesis inhibitors. J Clin Microbiol. 2008;46(9):2987-2991.
19. Okhuysen PC. Current concepts in travelers' diarrhea: epidemiology, antimicrobial resistance and treatment. Curr Opin Infect Dis. 2005;18(6):522-526. (Pubitemid 41634765)
20. Ohara T, Kojio S, Taneike I, et al. Effects of azithromycin on Shiga toxin production by Escherichia coli and subsequent host inflammatory response. Antimicrob Agents Chemother. 2002;46(11):3478-3483. (Pubitemid 35192914)
21. Ericsson CD, DuPont HL, Okhuysen PC, Jiang ZD, DuPont MW. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. J Travel Med. 2007;14(5):312-319. (Pubitemid 47460252)
22. Mellmann A, Bielaszewska M, Köck R, et al. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg Infect Dis. 2008;14(8):1287-1290.
23. Huang DB, Mohanty A, DuPont HL, Okhuysen PC, Chiang T. A review of an emerging enteric pathogen: enteroaggregative Escherichia coli. J Med Microbiol. 2006;55(Pt 10):1303-1311. (Pubitemid 44651654)
24. Weintraub A. Enteroaggregative Escherichia coli: epidemiology, virulence and detection. J Med Microbiol. 2007;56(Pt 1):4-8. (Pubitemid 46036267)
25. Huang DB, Dupont HL. Enteroaggregative Escherichia coli: an emerging pathogen in children. Semin Pediatr Infect Dis. 2004;15(4):266-271. (Pubitemid 39371108)
26. Wilson JB, Clarke RC, Renwick SA, et al. Vero cytotoxigenic Escherichia coli infection in dairy farm families. J Infect Dis. 1996;174(5):1021-1027. (Pubitemid 26357465)